1. Home
  2. GEVO vs CLDT Comparison

GEVO vs CLDT Comparison

Compare GEVO & CLDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GEVO
  • CLDT
  • Stock Information
  • Founded
  • GEVO 2005
  • CLDT 2009
  • Country
  • GEVO United States
  • CLDT United States
  • Employees
  • GEVO N/A
  • CLDT N/A
  • Industry
  • GEVO Major Chemicals
  • CLDT Real Estate Investment Trusts
  • Sector
  • GEVO Industrials
  • CLDT Real Estate
  • Exchange
  • GEVO Nasdaq
  • CLDT Nasdaq
  • Market Cap
  • GEVO 418.4M
  • CLDT 374.7M
  • IPO Year
  • GEVO 2011
  • CLDT 2010
  • Fundamental
  • Price
  • GEVO $1.73
  • CLDT $7.61
  • Analyst Decision
  • GEVO Buy
  • CLDT Strong Buy
  • Analyst Count
  • GEVO 2
  • CLDT 2
  • Target Price
  • GEVO $7.58
  • CLDT $10.75
  • AVG Volume (30 Days)
  • GEVO 9.4M
  • CLDT 264.3K
  • Earning Date
  • GEVO 08-11-2025
  • CLDT 08-06-2025
  • Dividend Yield
  • GEVO N/A
  • CLDT 4.72%
  • EPS Growth
  • GEVO N/A
  • CLDT N/A
  • EPS
  • GEVO N/A
  • CLDT 0.03
  • Revenue
  • GEVO $80,187,000.00
  • CLDT $310,140,000.00
  • Revenue This Year
  • GEVO $909.99
  • CLDT N/A
  • Revenue Next Year
  • GEVO $22.37
  • CLDT $0.45
  • P/E Ratio
  • GEVO N/A
  • CLDT $277.86
  • Revenue Growth
  • GEVO 341.75
  • CLDT N/A
  • 52 Week Low
  • GEVO $0.67
  • CLDT $5.83
  • 52 Week High
  • GEVO $3.39
  • CLDT $10.00
  • Technical
  • Relative Strength Index (RSI)
  • GEVO 57.77
  • CLDT 63.27
  • Support Level
  • GEVO $1.54
  • CLDT $7.57
  • Resistance Level
  • GEVO $1.86
  • CLDT $7.82
  • Average True Range (ATR)
  • GEVO 0.14
  • CLDT 0.16
  • MACD
  • GEVO 0.01
  • CLDT 0.06
  • Stochastic Oscillator
  • GEVO 31.15
  • CLDT 76.92

About GEVO Gevo Inc.

Gevo Inc is a renewable chemicals and biofuels company engaged in the development and commercialization of alternatives to petroleum-based products based on isobutanol produced from renewable feedstocks. The operating segments are the Gevo segment, GevoFuels segment, and the GevoRNG segment. By its segments, it is involved in research and development activities related to the future production of SAF, commercial opportunities for other renewable hydrocarbon products and isobutanol, including the development of its biocatalysts, and the produces-pipeline quality methane gas captured from dairy cow manure. The company derives maximum revenue from the GevoRNG segment.

About CLDT Chatham Lodging Trust (REIT) of Beneficial Interest

Chatham Lodging Trust is a U.S.-based real estate investment trust that invests in upscale extended-stay hotels. The firm operates across various states in the U.S., including California, New York, Texas, Florida, Minnesota, Massachusetts, and Pennsylvania among others. Substantially all of the company's assets are held and operated by its Operating Partnership, Chatham Lodging, LP. Chatham Lodging LP and its subsidiaries lease the overall company's hotels. The firm operates through a single segment because of the similar economic characteristics of its hotels. Chatham's revenue streams include Room, Food and beverage, and Other. Room comprises the majority of total revenue. Chatham's hotels operate under brands which include, Hilton, Marriott, and Hyatt.

Share on Social Networks: